Aurobindo Pharma gets ₹170 cr. GST demand over past refunds

Drugmaker Aurobindo Pharma on Thursday said the GST Department had issued orders directing the company to pay nearly ₹170 crore over refunds granted earlier.

The Additional Commissioner of Central Tax, Ranga Reddy GST Commissionerate, Hyderabad, has passed orders alleging erroneous refund of accumulated input tax credit (ITC) during September-December 2022. The disputed amount is ₹169,83,61,326 consisting of ₹84,91,80,663 GST and an equal penalty. The company will file an appeal before Commissioner of Central Tax (Appeals), Hyderabad. There is no material impact on the company’s financials or operations due to the said orders, Aurobindo Pharma said in a filing.